These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27736240)

  • 1. Medical and patient attitude towards vaginal atrophy: the AGATA study.
    Palma F; Della Vecchia E; Cagnacci A;
    Climacteric; 2016 Dec; 19(6):553-557. PubMed ID: 27736240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study.
    Palma F; Xholli A; Cagnacci A;
    Maturitas; 2018 Feb; 108():18-23. PubMed ID: 29290210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of vaginal atrophy: a real mess. Results from the AGATA study.
    Palma F; Xholli A; Cagnacci A;
    Gynecol Endocrinol; 2017 Sep; 33(9):702-707. PubMed ID: 28391746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and association between objective signs and subjective symptoms of vaginal atrophy: the AGATA study.
    Cagnacci A; Carbone MM; Palma F;
    Menopause; 2016 Oct; 23(10):1139-45. PubMed ID: 27300116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: The AGATA study.
    Palma F; Volpe A; Villa P; Cagnacci A;
    Maturitas; 2016 Jan; 83():40-4. PubMed ID: 26421474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.
    Nappi RE; Palacios S; Panay N; Particco M; Krychman ML
    Climacteric; 2016 Apr; 19(2):188-97. PubMed ID: 26581580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal atrophy across the menopausal age: results from the ANGEL study.
    Cagnacci A; Xholli A; Sclauzero M; Venier M; Palma F; Gambacciani M;
    Climacteric; 2019 Feb; 22(1):85-89. PubMed ID: 30601037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal Health: Insights, Views & Attitudes (VIVA-LATAM): results from a survey in Latin America.
    Nappi RE; de Melo NR; Martino M; Celis-González C; Villaseca P; Röhrich S; Palacios S
    Climacteric; 2018 Aug; 21(4):397-403. PubMed ID: 29741110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
    Vicariotto F; Raichi M
    Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyspareunia Related to GSM: Association of Total Vaginal Thickness via Transabdominal Ultrasound.
    Balica AC; Cooper AM; McKevitt MK; Schertz K; Wald-Spielman D; Egan S; Bachmann GA
    J Sex Med; 2019 Dec; 16(12):2038-2042. PubMed ID: 31542351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CLOSER (CLarifying Vaginal Atrophy's Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners.
    Nappi RE; Kingsberg S; Maamari R; Simon J
    J Sex Med; 2013 Sep; 10(9):2232-41. PubMed ID: 23809691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms, attitudes and treatment perceptions of vulvo-vaginal atrophy in UK postmenopausal women: Results from the REVIVE-EU study.
    Domoney C; Short H; Particco M; Panay N
    Post Reprod Health; 2020 Jun; 26(2):101-109. PubMed ID: 32627698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey.
    Nappi RE; Particco M; Biglia N; Cagnacci A; Di Carlo C; Luisi S; Paoletti AM
    Maturitas; 2016 Sep; 91():74-80. PubMed ID: 27451324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes and approaches to vaginal atrophy in postmenopausal women: a focus group qualitative study.
    Utian WH; Maamari R
    Climacteric; 2014 Feb; 17(1):29-36. PubMed ID: 24083795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy.
    Mattsson LÅ; Ericsson Å; Bøgelund M; Maamari R
    Maturitas; 2013 Mar; 74(3):259-63. PubMed ID: 23312488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions.
    Palacios S; Cancelo MJ; Castelo Branco C; Llaneza P; Molero F; Borrego RS
    Climacteric; 2017 Feb; 20(1):55-61. PubMed ID: 28042734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal Health: Insights, Views & Attitudes survey in Latin America (VIVA-LATAM): focus on Brazil.
    Pompei LM; Wender MCO; de Melo NR; Kulak J; Pardini D; Machado RB; Fernandes CE; Palacios S; Nappi RE
    Climacteric; 2021 Apr; 24(2):157-163. PubMed ID: 32869682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe.
    DiBonaventura M; Luo X; Moffatt M; Bushmakin AG; Kumar M; Bobula J
    J Womens Health (Larchmt); 2015 Sep; 24(9):713-22. PubMed ID: 26199981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An effective non-hormonal option with high tolerability for mild to moderate symptoms of vaginal dryness associated with menopause.
    Eichler S; Panz M; Harder A; Masur C; Häuser M; Wiesche ESZ
    Maturitas; 2024 Jul; 185():107978. PubMed ID: 38583316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey.
    Nappi RE; Kokot-Kierepa M
    Climacteric; 2012 Feb; 15(1):36-44. PubMed ID: 22168244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.